1 completed, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow vaxfectin: new trials by email Literature Review of vaxfectin trials Research Report on vaxfectin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine CyMVectin - Congenital Cytomegalovirus Infection | Phase 1 | Withdrawn | Virginia Commonwealth University | 2015-11-01 | 2018-03-01 | |
| Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease Tetravalent Dengue Vaccine (TVDV), Tetravalent Dengue Vaccine (TVDV) with Vaxfectin® (low-dose), Tetravalent Dengue Vaccine TVDV with Vaxfectin® (High Dose) - Dengue Disease, Dengue Fever | Phase 1 | Completed | U.S. Army Medical Research and Development Command | 40 | 2011-12-01 | 2016-11-04 |
Cytomegalovirus Infections (1) · Dengue (1)
U.S. Army Medical Research and Development Command (1) · Virginia Commonwealth University (1)
United States (1)
Janine R Danko, MD (1) · Michael A McVoy, Ph.D. (1)